4.2. Study Design, Blinding, Random Allocation, and Concealment 
oropharyngeal cancer
OROPHARYNGEAL CANCER, BLIND
A multi-center blind randomized placebo-controlled trial was conducted. Seventy-two patients with advanced-stage oral or oropharyngeal cancer were randomly assigned with minimization for age and baseline quality of life scores into the study group (